NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Adicet Bio Inc (NASDAQ: ACET)

 
ACET Technical Analysis
3
As on 28th Jan 2022 ACET Share Price closed @ 11.69 and we RECOMMEND Sell for LONG-TERM with Stoploss of 12.21 & Sell for SHORT-TERM with Stoploss of 12.61 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACET Share Price

Open 11.78 Change Price %
High 11.93 1 Day 0.16 1.39
Low 11.17 1 Week -1.23 -9.52
Close 11.69 1 Month -2.94 -20.10
Volume 228149 1 Year -0.20 -1.68
52 Week High 18.33 | 52 Week Low 6.29
 
NASDAQ USA Most Active Stocks
AAPL 170.33 6.98%
AMD 105.24 2.57%
SOFI 11.10 -2.29%
HOOD 12.73 9.65%
SNDL 0.45 4.65%
LCID 27.15 -5.40%
XELA 0.63 16.67%
INTC 47.73 -0.67%
NVDA 228.40 4.08%
AAL 15.64 -0.89%
 
NASDAQ USA Top Gainers Stocks
ZJZZT 37.50 79.86%
FRWAW 0.78 73.33%
DSKEW 0.05 66.67%
AUUDW 0.80 53.85%
CMAXW 1.19 41.67%
ARTLW 0.17 41.67%
TLMDW 0.11 37.50%
TIOAW 0.66 32.00%
SVOK 11.93 31.39%
BOWXW 2.97 29.13%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
BCDAW 0.43 -51.69%
CETXW 0.01 -50.00%
MPACR 0.21 -47.50%
IKNX 19.52 -42.42%
CHPMW 0.16 -40.74%
OTLKW 0.03 -40.00%
VPCBW 0.47 -38.96%
ROVRW 1.30 -34.34%
VMACW 0.30 -33.33%
 
 
ACET
Daily Charts
ACET
Intraday Charts
Whats New @
Bazaartrend
ACET
Free Analysis
 
ACET Important Levels Intraday
RESISTANCE13.15
RESISTANCE12.68
RESISTANCE12.39
RESISTANCE12.10
SUPPORT11.28
SUPPORT10.99
SUPPORT10.70
SUPPORT10.23
 
ACET Target for Month January
4th UP TARGET21.31
3rd UP TARGET18.22
2nd UP TARGET16.32
1st UP TARGET14.41
1st DOWN TARGET8.97
2nd DOWN TARGET7.06
3rd DOWN TARGET5.16
4th DOWN TARGET2.07
 
ACET Weekly Target
4th UP TARGET15.83
3rd UP TARGET14.50
2nd UP TARGET13.68
1st UP TARGET12.86
1st DOWN TARGET10.52
2nd DOWN TARGET9.70
3rd DOWN TARGET8.88
4th DOWN TARGET7.55
 
ACET Target for Year 2022
4th UP TARGET35.28
3rd UP TARGET27.71
2nd UP TARGET23.04
1st UP TARGET18.36
1st DOWN TARGET5.02
2nd DOWN TARGET0.34
3rd DOWN TARGET-4.33
4th DOWN TARGET-11.9
 
 
ACET Other Details
Segment EQ
Market Capital 275435872.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACET Address
ACET
 
ACET Latest News
 
Your Comments and Response on Adicet Bio Inc
 
ACET Business Profile
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase 1 clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors, including hepatocellular carcinoma, gastric cancer, and squamous cell carcinoma of the lung. The company is based in Boston, Massachusetts. Address: 500 Boylston Street, Boston, MA, United States, 02116
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service